- Breaking down silos and establishing a linkable data infrastructure to link data at the patient level
- Ensuring workflow clarity and bridging the gap between AI/ML specialists and clinical development teams
- Designing more representative and equitable clinical trials, improving site identification and improvement, and enhance operational efficiencies
- Effectively designing trials for data integration in preparation for engagements such as NDAs/SNDA, DSMBs, pre-NDA, Advisory Boards, and Regulatory Interaction
- Enabling a new level
Speaker(s):
Murthy Devarakonda
Executive Director and Head of NLP, AI Innovation Center
Novartis
Subha Madhavan
Vice President & Head of Clinical AI / ML
Pfizer
Mariann Micsinai-Balan
Vice President, Head of Data Science and Statistical Methodology
Bristol Myers Squibb
Tala Fakhouri
Associate Director for Policy Analysis
FDA